Description
JUPIBINE-200
Gemcitabine 200 mg Injection
JUPIBINE-200
JUPIBINE-200
Gemcitabine 200 mg Injection
FDA Approved, GOLD-STANDARD monotherapy in management of advanced pancreatic cancer
Most prescribed conventional anti-cancer drug worldwide
Related products
-
JUPIPAC-260
JUPIPAC-260 Paclitaxel 260 mg Injection The first microtubule targeting agent Broad activity in …Read more -
JUPITAXEL-20
JUPITAXEL-20 Docetaxel 20mg Injection For the management of multiple metastatic and non-resectable …Read more -
JUPITRO-25
JUPITRO-25 Eltrombopag 25 mg Tablets Stimulates the production of platelets An orally administered, …Read more
